SCHEMBL568672

SCHEMBL568672

O=C(O)c1cc(Br)no1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10999756 0.98 HCAR2 (0.55)
SCHEMBL3131538 0.80
SCHEMBL1641444 0.80
SCHEMBL9819411 0.80
SCHEMBL568129 0.77 CHRNA4 (0.43)
SCHEMBL6074169 0.77 CHRNA4 (0.43)
SCHEMBL2806245 0.76 HCAR2 (0.61)
SCHEMBL15004589 0.75 CHRNA4 (0.42)
SCHEMBL630565 0.74
SCHEMBL11619922 0.74 PTPN1 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0016255-B1 ISOXAZOLE DERIVATIVE, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME ZAMBON S.p.A. (IT) 1983-09-28 EP claimed
EP-0016255-A2 Isoxazole derivative, preparation thereof and pharmaceutical compositions containing the same ZAMBON S.p.A. (IT) 1980-10-01 EP claimed
EP-2064194-B1 N-HYDROXYAMIDINOHETEROCYCLIC COMPOUNDS AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE INCYTE HOLDINGS CORP (US) 2018-11-07 EP disclosed
EP-2346868-B1 AZAINDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2016-01-27 EP disclosed
EP-2346868-B1 AZAINDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2016-01-27 EP disclosed
US-20130296279-A1 SUBSTITUTED TETRACYCLINES CONCERT PHARMACEUTICALS INC. 2013-11-07 US disclosed
US-20130296279-A1 SUBSTITUTED TETRACYCLINES CONCERT PHARMACEUTICALS INC. 2013-11-07 US disclosed
US-20130296279-A1 SUBSTITUTED TETRACYCLINES CONCERT PHARMACEUTICALS INC. 2013-11-07 US disclosed
US-8507541-B2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION (US) 2013-08-13 US disclosed
US-8338610-B2 Pyridinyl compounds useful as intermediates BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-25 US disclosed
US-8338610-B2 Pyridinyl compounds useful as intermediates BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-25 US disclosed
EP-0207955-A1 PROCESS FOR THE PREPARATION OF 3,5-DISUBSTITUTED ISOXAZOLES. ZAMBON SPA (IT) 1987-01-14 EP disclosed
WO-1986003490-A1 PROCESS FOR THE PREPARATION OF 3,5-DISUBSTITUTED ISOXAZOLES ZAMBON S.P.A. (IT) 1986-06-19 WO disclosed
US-4520200-A CHEMICAL INTERMEDIATES FOR BRONCHODILATOR AGENT ZAMBON S.P.A. (IT) 1985-05-28 US disclosed
US-4520200-A CHEMICAL INTERMEDIATES FOR BRONCHODILATOR AGENT ZAMBON S.P.A. (IT) 1985-05-28 US disclosed
EP-0016255-B1 ISOXAZOLE DERIVATIVE, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME ZAMBON S.p.A. (IT) 1983-09-28 EP disclosed
US-4276299-A BRONCHODILATOR AGENTS ZAMBON S.P.A. (IT) 1981-06-30 US disclosed
US-4276299-A BRONCHODILATOR AGENTS ZAMBON S.P.A. (IT) 1981-06-30 US disclosed
EP-0016255-A2 Isoxazole derivative, preparation thereof and pharmaceutical compositions containing the same ZAMBON S.p.A. (IT) 1980-10-01 EP disclosed
EP-0016255-A2 Isoxazole derivative, preparation thereof and pharmaceutical compositions containing the same ZAMBON S.p.A. (IT) 1980-10-01 EP disclosed